Xiaobei Technology

Xiaobei Technology develops innovative healthcare technology solutions that enhance patient engagement through digital platforms, facilitating telemedicine services for improved healthcare delivery. Founded in 2016 in Beijing, China, Xiaobei Technology operates under QingHeXiaoBei Inc. , providing a digital platform for telemedicine. CEO Jun Zhang leads the company, which has completed 2 deals with the most recent deal occurring on January 17, 2017, when it raised Series B funding from Shunwei Capital Partners and Xiaomi Group.

Beiyisheng, the primary brand of Xiaobei Technology, offers healthcare technology solutions aimed at improving patient engagement and medical consultations. The company connects patients with healthcare professionals via a digital platform, facilitating telemedicine services that address various healthcare needs. Its services enhance accessibility to medical advice, timely consultations, and follow-up care, ultimately improving healthcare delivery for domestic clients in China while also expanding internationally. Beiyisheng generates revenue through a subscription model that allows clients, including individual patients and healthcare institutions, to access telemedicine consultations and digital health tools.

Clients incur a recurring subscription fee for continued platform access, with additional revenue generated through partnerships with healthcare providers that may involve revenue-sharing arrangements. Xiaobei Technology plans to enhance its service offerings by developing new products aimed at improving telemedicine functionalities, with specific launch dates to be announced. The company is also targeting expansion into international markets beyond China, focusing on regions that present growth opportunities by 2025. The recent Series B funding raised in January 2017 will be allocated to support these product developments and market expansions.